semaglutide 7.2 mg clinical trial Once-weekly 7·2 in adults with obesity (STEP UP): a randomised, controlled, phase 3b Efficacy and safety of once-weekly

There is no FDA-approved generic version of tirzepatide

Positive routines, like balanced meals and steady sleep, make it easier to manage weight even after reaching a maintenance dose

Tirzepatide Weight Loss Performance (SURMOUNT Trials) In the pivotal SURMOUNT-1 clinical trials, Tirzepatide was evaluated over 72 weeks in adults with obesity or overweight conditions without type 2 diabetes

This requirement creates particular challenges in regions with unreliable electricity, hot climates, or limited access to medical-grade refrigeration

Aim for 150 minutes of moderate activity per week, with at least two sessions of resistance training

Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial